Neutralizing antibodies and safety of a COVID-19 vaccine against SARS-CoV-2 wild-type and Omicron variants in solid cancer patients
针对SARS-CoV-2野生型和Omicron变异株的COVID-19疫苗在实体瘤患者中的中和抗体和安全性
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0310781
Chewaskulyong, Busyamas; Satjaritanun, Pattarapong; Ketpueak, Thanika; Suksombooncharoen, Thatthan; Charoentum, Chaiyut; Nuchpong, Nuttaphoom; Tantraworasin, Apichat
